Filter by ContentType
Analytical characterization in an era of precision vaccinology
Julia O’Neill
02 August 2024
Commentary
Impact of pharmacometrics in advancing mRNA therapeutics and vaccines
Husain Attarwala
01 August 2024
Commentary
Self-amplifying RNA—opportunities and challenges
Rachel Groppo
01 July 2024
Commentary
Vaccine security and self-reliance in South East Asia
Tuck Seng Wong, Kiat Ruxrungtham
05 March 2024
Commentary
Facilitating quality by design through patient-centric specifications
Timothy Schofield
28 September 2023
Commentary
Testing in times of COVID-19: legacy & unfinished agenda
C Batista, Y Ben Amor, O Ergonul et al
23 August 2023
Commentary
Vaccine supply chains: priority areas of action emerging from the COVID-19 pandemic
P Yadav, C Batista, R Anupindi et al
21 March 2023
Commentary
Breaking the cycle: building vaccine manufacturing capacity in Africa
Patrick Tippoo
07 December 2022
Commentary
Process modeling in the CMC of vaccines: are we doing it right?
Harini Narayanan, Christopher Love
28 November 2022
Commentary
A fresh look at analytical methods for vaccines
Timothy Schofield
26 October 2022
Commentary
Why vaccinate children against COVID-19?
D C Kaslow, C Batista, M Elena Bottazzi et al
13 October 2022
Commentary
Healthcare in global crisis: preparations needed during the COVID-19 pandemic
B Lall, D Chaudhry, S Shoham et al
23 September 2022
Commentary
mRNA Vaccines: a growing and complex IP landscape
Robert Burrows, Ellen Lambrix
04 September 2022
Commentary
EATRIS: providing the right tools, at the right time, for vaccine development in a pandemic
D Morrow, L Gabriele, A Andreu et al
26 June 2022
Commentary
COVID-19 vaccine supply chain management: a LMIC perspective
Darin Zehrung
12 June 2022
Commentary
COVID-19 vaccine supply chain management: a US perspective
Michael Angelastro, Robert A Johnson
08 June 2022
Commentary
Should we vaccinate against long-COVID?
P Hotez, C Batista, Y Ben Amor et al
03 June 2022
Commentary
COVID-19: how is the pandemic changing the vaccines space?
Nicholas Jackson
24 May 2022
Commentary